IN OUR PREVIOUS PAPERS
we showed that leucocytes from patients afflicted with a colorectal carcinoma had a significantly inhibited migration when they were reacted with a saline extract of an established colonic tumour line (HT29). Leucocytes from patients with a ehronic non-cancerous intestinal disease, taken as controls, also gave many positive reactions with the same extract. In order to explain this similar reactivity, we elaborated 2 hypotheses. In the first, we considered that HT29 extract contained only tissue antigens, to which both cancerous and non-cancerous leucocytes were sensitized. In the second, HT29 extract might contain both tissue and cancer-associated antigens responsible for the sensitization of non-cancerous and cancerous leucocytes, respectively. A separation between both types of antigens would thus be useful, if possible.
With the aim of exploring further the reactivity of cancerous and non-cancerous leueocytes, we studied their sensitization to antigens in foetal colon extract. The observation that many experimental tumours, especially those of the intestine (Steele & Sjogren, 1974; Steele et al., 1975; Martin et al., 1976) bear antigens of foetal type, suggested that those responsible for sensitization of cancerous leucocytes might also be of that type.
To our surprise, we found that cancerous leucocytes were only weakly or not at all sensitized to foetal colon antigens, which by contrast provoked a strong reaction in non-cancerous leucocytes. Blood samples were obtained from 40 healthy blood donors and from 42 patients with carcinoma of the colon or rectum. In all cases the diagnosis was proved histologically. The extension of the tumour was graded according to Dukes' classification.
Blood was also sampled from 17 patients with a non-cancerous disease of the intestine, including 4 ulcerative colitis, 6 Crohn's disease, 5 severe sigmoiditis, one villous tumour and one diffuse polyposis.
In all patients, the blood was taken before operation.
The colons from 4 foetuses (obtained at gestational ages of 3, 3-, 4 and 4-months) were first kept frozen. They were then thawed, pooled and ground with an equal volume of PBS in a Ultraturrax grinder (no previous separation of the mucosa was attempted). The mixture was centrifuged for 5 min at 3000 rev/min and the supernatant decanted. The protein concentration of this supernatant was measured by Lowry's method. The product was kept frozen. When necessary an aliquot was thawed and diluted in Waymouth's medium to the required concentration.
The leucocyte-migration-inhibition technique described by Beaulieu (1976) was used throughout this study, as previously in our laboratory (Burtin et al., 1977 (Burtin et al., , 1978 .
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Briefly, heparinized blood was sedimented in the presence of Plasmagel (Roger Bellon, France) 5 ml for 20 ml blood. The white layer containing plasma was aspirated with a Pasteur pipette, and centrifuged at 1500 rev/min for 5 min, the pellet was resuspended in Waymouth's medium, adjusted to 108 cells/ml, and incubated for 2 h with antigen extract at various concentrations. Leucocytes were then put in plastic capillary tubes (Portex, Hythe, England). These tubes were centrifuged, cut at the upper level of the white layer, and inserted in glass capillaries containing Waymouth's medium plus 10o inactivated AB serum and the antigen extract. These glass capillaries played the role of migration chambers. Hence the leucocyte migration was unidirectional.
Six antigen solutions were used in these experiments, either for leucocyte incubation or for migration: 2 mg, I mg, 500, 200, 100 and 50 jug/ml. For 1 normal, 1 non-cancerous and 5 cancerouis leucocyte samples, however, 500tug and 50utg solutions were omitted.
After Table) .
Leucocytes from cancerous patients reacted only weakly with foetal colon extract. The MI means were only slightly decreased, and never significantly, in comparison to those of normal leucocytes. However, the tenth-percentile test showed a difference between cancerous and normal leucocytes (Figure) . The former were sig- (Table) . In fact, a strong inhibition was observed in many cases (7/16 for the dilution at 500 ,ug/ml) irrespective of diagnosis (sigmoiditis, Crohn's disease, ulcerative colitis, etc.) and for all or almost all the antigen concentrations. Stimulation was rare. In one case, stimulation was observed for low concentrations and inhibition for high concentrations of foetal colon extract. The reverse was seen in another case.
Our data show an important difference between cancerous and non-cancerous leucocytes. In opposition to our working hypothesis, the former were only weakly sensitized and in a limited number of cases (300o for the 500pg/ml concentration, which was the only one to give significant results). Stimulation of leucocyte migration was the more frequent reaction. By contrast, leucocytes of non-cancerous patients were often strongly inhibited by foetal colon extract at various concentrations (similar results had been obtained by Bendixen (1969) ). One can wonder whether this discrepancy was due to a difference in the intensity of leucocyte sensitization, or reactions to different antigens.
For some authors, such as Kjaer (1975) and Zoller et al. (1977) stimulation of leucocyte migration corresponds to a weak reaction, and inhibition to a stronger one, generally obtained with higher concentrations of the antigen extract. For example, in Z6ller's experiments (Zoller et al., 1977 (Zoller et al., , 1979 , the same extract at concentrations of 1 and 5 mg/ml provoked respectively a stimulation and an inhibition of leucocyte migration. In our studies, however, a 4-fold increase in the protein concentration of the antigenic extract (from 500 ,ug to 2 mg/ml) transformed stimulation into inhibition in only one case. Hence, to explain the different reactivity to foetal colon extract of cancerous and non-cancerous leucocytes, the 2-antigen hypothesis is not unlikely: one antigen would be responsible for the stimulation of cancerous leucocyte We already proposed this 2-antigen hypothesis in our previous work (Burtin et al., 1978) after showing that leucocytes of non-cancerous intestinal diseases reacted as much as those of cancer patients to HT29 tumour extract in the LMI test. This hypothesis was purely speculative, however, as the data did not favour it. By contrast, it is more attractive in our present study. One could even imagine that antigen(s) of the HT29 extract, that sensitized non-cancerous leucocytes, were also in the foetal colon. Hence, a separation of HT29 extract by elimination of foetal colon antigens would render LMI reaction more specific for cancerous leucocytes.
The poor reaction of cancerous leucocytes with foetal colon extract disagrees with the data given by experimental tumours of the intestine. The animals, mainly rats, bearing these tumours were seen to have antibodies (Martin et al., 1976; Steele & Sjogren, 1974) and sensitized lymphocytes (Steele & Sjogren, 1974) reacting to antigens of the foetal intestine. Furthermore, Bansal et al. (1978) was able to protect rats against the graft of chemically induced intestinal tumours by immunization with syngeneic foetal colon and liver extract. In other studies, 2 categories of foetal antigens have been demonstrated, some organ-specific, and especially specific to intestine, others being common to several organs (Steele et al., 1975) .
The situation in human tumours is not so clear. However, Zoller et al. (1979) found leucocyte reactivity in patients with carcinomas of various organs (stomach, colon and lung) to human foetal extracts by the LMI method. These results are quite contrary to ours. Actually many differences exist between Zoller's experiments and ours. The main one lies in the type of extracts used in the tests: Z6ller's extracts were prepared with 3M KCI from whole foetuses, and probably contained more antigens than our extracts obtained with saline fromn foetal coloni onily. That would mean that reactions observed by Zoller's group could be explained by the sensitization of cancerous leucocytes to non-organ-specific foetal antigens.
